e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tuberculosis after a borderline QuantiFERON result during screening before infliximab
Jonathan W. Uzorka, Nathalie M. Delfos, Anne M.C. Witte, Henk Scheper, Dick van Soolingen, Sandra M. Arend
Source:
Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018
Journal Issue:
August
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jonathan W. Uzorka, Nathalie M. Delfos, Anne M.C. Witte, Henk Scheper, Dick van Soolingen, Sandra M. Arend. Tuberculosis after a borderline QuantiFERON result during screening before infliximab. Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Year: 2017
Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
QuantiFERON®-TB or QFT in sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
Low real-world utility of IGRA when screening for LTBI in a low incidence setting
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Evaluation of IP-10 in IGRA for LTBI diagnosis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Diagnostic efficiency of quantiferon TB gold test in the diagnosis of tuberculous pleurisy
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept